http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
a companion to Braunwald's heart disease
1 online resource (xxii, 615 pages) : illustrations
Clinical hypertension is one of the most serious long-term problems associated with heart disease. This companion to Braunwald's Heart Disease focuses in depth on this key area of cardiovascular medicine. Complete with practical clinical tools for management, it helps you manage the chronic problems of your hypertensive patients. It covers everything from epidemiology and pathophysiology through diagnosis, risk stratification, treatment, outcome studies, concomitant diseases, special populations and special situations, and future treatments. Addresses management of all special populations with chronic hypertensive disease. Includes Clinical Pearls for reducing complications of hypertension. Discusses hypertension and concomitant disease. Provides information on the practical management of hypertension and its role in complex diseases Emphasizes prevention of hypertensive diseases. Covers behavior management as an integral part of treatment plan for hypertensives and pre-hypertensives. Assesses drugs and other forms of treatment. Presents current clinical guidelines for the U.S., Canada, and Europe. Encourages aggressive patient management to ensure minimal risk of further cardiovascular problems.
1. Epidemiology of hypertension -- 2. Genetics of hypertension -- 3. Pathophysiology of hypertension -- 4. Defining hypertension -- 5. Office blood pressure measurement -- 6. Home monitoring of blood pressure -- 7. Ambulatory blood pressure monitoring in hypertension -- 8. Secondary hypertension: renovascular hypertension -- 9. Secondary hypertension: mineralcorticoid excess states -- 10. Secondary hypertension: pheochromocytoma -- 11. Secondary hypertension: sleep apnea -- 12. Rare and unusual forms of hypertension -- 13. The natural history of untreated hypertension -- 14. The special problem of isolated systolic hypertension -- 15. Assessment of hypertensive target organ damage -- 16. Prediction of global cardiovascular risk in hypertension -- 17. Diet and blood pressure -- 18. Diruretic therapy in cardiovascular disease -- 19. B-Blockers in hypertension -- 20. Angiotensin-converting enzyme inhibitors -- 21. Angiotensin receptor blockers -- 22. A-Blockers -- 24. New and investigational drugs for hypertension -- 25. Design of outcomes studies -- 26. Meta-analysis of hypertension trials -- 27. Ischemic heart disease in hypertension -- 28. Heart failure in hypertension -- 29. Kidney disease in hypertension -- 30. Transplant hypertension -- 31. Obesity in hypertension -- 32. Peripheral arterial disease in hypertension -- 33. Cerebrovascular disease in hypertension -- 34. Hypertension in diabetes mellitus -- 35. Dyslipidemia in hypertension -- 36. Hypertension in pregnancy -- 37. Hypertension in children and adolescents -- 38. Hypertension in the elderly -- 39. Hypertension in African Americans -- 40. Hypertension in Hispanics -- 41. Hypertension in East Asians and Pacific Islanders -- 42. Hypertension in South Asians -- 43. Resistant hypertension -- 44. Hypertension and the perioperative period -- 45. Hypertensive emergencies and urgencies -- 46. Hypertension disease management services -- 47. Antihypertensive drug development: a regulatory perspective -- 48. U.S. and Canadian guidelines for hypertension -- 49. European, American, and British guidelines: similarities and differences.
Companion v. to: Braunwald's heart disease / [edited by] Douglas P. Zipes [and others]. 7th ed. ©2005.
Includes bibliographical references and index.
179521:175883 Elsevier Science & Technology